The China scar treatment market has witnessed significant growth in the recent years. Scar treatment products help improve scar appearance and reduce scar visibility. These products are used to treat both surgical and non-surgical scars. Some of the commonly used scar treatment products include creams, gels, sheets, laser therapy, and surgical intervention. The advancement in technologies has enabled development of innovative scar treatment products that can effectively minimize the appearance of scars.
The Global China scar treatment market is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the China Scar Treatment Market Growth are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. These players are focusing on new product launches and expanding their regional presence to strengthen their market position.
The key opportunities in the China scar treatment market include increasing patient awareness about various scar treatment options and growth in medical tourism industry.
The market is witnessing higher growth in Asia Pacific region owing to rising disposable incomes, growing medical tourism industry and increasing patient awareness.
Market Drivers
Rising number of road accidents in China has significantly increased the number of surgical procedures which is one of the major factors driving the demand for scar treatment products. As per estimates, around 5 million road accidents occur annually in China resulting in huge treatment costs. Scar treatment finds wide application in minimizing disfigurement caused due to accidents. This is expected to drive the growth of China scar treatment market over the forecast period.
PEST Analysis
Political: The scar treatment market is regulated by the State Food and Drug Administration(SFDA) of China. Regulations around usage and approval of new scar treatment products impacts the market.
Economic: Higher disposable income is allowing Chinese consumers to spend more on aesthetic procedures like scar treatments. Growing medical tourism also benefits the market.
Social: Increasing awareness about appearance and look has boosted demand for procedures to reduce visible scarring after accidents or surgery. Social media is promoting beauty standards and treatments.
Technological: Use of lasers, injectable treatments and sophisticated scar revision procedures allow removal/reduction of scars with minimal side effects and faster recovery. New application methods are improving outcomes.
Geographical Regions with High Market Concentration
The scar treatment market in China is majorly concentrated in tier 1 cities like Beijing, Shanghai, Guangzhou and Shenzhen accounting for over 60% of the total market value. These cities have major private hospitals, dermatology clinics and aesthetic centers catering to a population with higher spend capacity on scarring treatments.
Fastest Growing Regional Market
The southern region of China comprising of provinces like Guangdong and Fujian is expected to witness highest growth over the forecast period. Improving healthcare infrastructure in cities like Shenzhen and Xiamen along with climbing incomes is increasing accessibility to advanced scar treatments in these regions. Growing medical tourism from Southeast Asia to Guangzhou and Shenzhen hospitals is also contributing to market growth.
Get more insights on China Scar Treatment Market
Also read related article on China Scar Treatment Market
Comments
0 comment